TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial

  1. Ware, L.B.
  2. Soleymanlou, N.
  3. McAuley, D.F.
  4. Estrada, V.
  5. Diaz, G.A.
  6. Lacamera, P.
  7. Kaste, R.
  8. Choi, W.
  9. Gupta, A.
  10. Welte, T.
Revue:
Thorax

ISSN: 1468-3296,  0040-6376

Année de publication: 2023

Volumen: 78

Número: 8

Pages: 816-824

Type: Article

DOI: 10.1136/THORAX-2022-219668 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus